Clinical Characteristics of Aquagenic Pruritus in Patients With Myeloproliferative Neoplasms

Completed

• Conditions: Myeloproliferative Disorder

• Registration Number: NCT03688490
• Lead Sponsor: University Hospital, Brest

Brief Summary

Description of the characteristics of aquagenic pruritus expressed by patients suffering from myeloproliferative neoplasms.

Prospective work based on the distribution of a dedicated questionnaire.

Detailed Description

Patients with myeloproliferative neoplasms identified and followed in our Institution (Brest University Hospital). Patients could be followed for polycythemia vera or essential thrombocythemia or myelofibrosis.

Distribution of the questionnaire to each patients with myeloproliferative neoplasms (treated or not) suffering from aquagenic pruritus.

Analyse of each characteristic of the aquagenic pruritus by a statistician and publication at the end.

Study Timeline

• Study Start: 2013-07-17
• Primary Completion: 2013-11-04
• Study Completion: 2013-11-04
• Status Verified: 2018-08
• Study First Submitted: 2018-09-20
• Study First Submitted QC: 2018-09-26
• Study First Posted: 2018-09-28
• Last Update Submitted: 2019-06-27
• Last Update Posted: 2019-07-01

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 70

Inclusion Criteria

• patients followed with myeloproliferative neoplasms
• suffering from aquagenic pruritus

Exclusion Criteria

• Unable to fulfil the questionnaire
• No written informed consent

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Intensity of the pruritus	15 days	Analogic Visual Scale, from 0 to 10, Worse if \>6

Secondary Outcome Measures

Name	Time	Method
Duration of the pruritus	15 days	Timing expresses in minutes